Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine.

Saved in:
Bibliographic Details
Title: Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine.
Authors: Folschweiller N; GSK, Wavre, Belgium., Behre U, Dionne M; Centre Hospitalier Universitaire, Québec., Durando P; Department of Health Sciences, University of Genoa.; IRCCS Ospedale Policlinico AOU San Martino-IST, Genoa., Esposito S; Pediatric Clinic, Department of Surgical and Biomedical Sciences, Università degli Studi di Perugia, Perugia, Italy., Ferguson L; Colchester Research Group, Truro., Ferguson M; Colchester Research Group, Truro., Hillemanns P; MedizinischeHochschule Hannover; Hannover., McNeil SA; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax., Peters K, Ramjattan B; First Line Medical Services, St. John's, Canada., Schwarz TF; Institute of Laboratory Medicine and Vaccination Centre, Klinikum Würzburg Mitte, Standort Juliusspital, Würzburg, Germany., Supparatpinyo K; Chiang Mai University, Thailand., Suryakirian PV; GSK, Bangalore, India., Janssens M; GSK, Wavre, Belgium., Moris P; GSK, Wavre, Belgium., Decreux A; GSK, Wavre, Belgium., Poncelet S; GSK, Wavre, Belgium., Struyf F; GSK, Wavre, Belgium.
Source: The Journal of infectious diseases [J Infect Dis] 2019 May 05; Vol. 219 (11), pp. 1799-1803.
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30715452
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Folschweiller+N%22">Folschweiller N</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Behre+U%22">Behre U</searchLink><br /><searchLink fieldCode="AU" term="%22Dionne+M%22">Dionne M</searchLink>; Centre Hospitalier Universitaire, Québec.<br /><searchLink fieldCode="AU" term="%22Durando+P%22">Durando P</searchLink>; Department of Health Sciences, University of Genoa.; IRCCS Ospedale Policlinico AOU San Martino-IST, Genoa.<br /><searchLink fieldCode="AU" term="%22Esposito+S%22">Esposito S</searchLink>; Pediatric Clinic, Department of Surgical and Biomedical Sciences, Università degli Studi di Perugia, Perugia, Italy.<br /><searchLink fieldCode="AU" term="%22Ferguson+L%22">Ferguson L</searchLink>; Colchester Research Group, Truro.<br /><searchLink fieldCode="AU" term="%22Ferguson+M%22">Ferguson M</searchLink>; Colchester Research Group, Truro.<br /><searchLink fieldCode="AU" term="%22Hillemanns+P%22">Hillemanns P</searchLink>; MedizinischeHochschule Hannover; Hannover.<br /><searchLink fieldCode="AU" term="%22McNeil+SA%22">McNeil SA</searchLink>; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax.<br /><searchLink fieldCode="AU" term="%22Peters+K%22">Peters K</searchLink><br /><searchLink fieldCode="AU" term="%22Ramjattan+B%22">Ramjattan B</searchLink>; First Line Medical Services, St. John's, Canada.<br /><searchLink fieldCode="AU" term="%22Schwarz+TF%22">Schwarz TF</searchLink>; Institute of Laboratory Medicine and Vaccination Centre, Klinikum Würzburg Mitte, Standort Juliusspital, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Supparatpinyo+K%22">Supparatpinyo K</searchLink>; Chiang Mai University, Thailand.<br /><searchLink fieldCode="AU" term="%22Suryakirian+PV%22">Suryakirian PV</searchLink>; GSK, Bangalore, India.<br /><searchLink fieldCode="AU" term="%22Janssens+M%22">Janssens M</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Moris+P%22">Moris P</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Decreux+A%22">Decreux A</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Poncelet+S%22">Poncelet S</searchLink>; GSK, Wavre, Belgium.<br /><searchLink fieldCode="AU" term="%22Struyf+F%22">Struyf F</searchLink>; GSK, Wavre, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2019 May 05; Vol. 219 (11), pp. 1799-1803.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30715452
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/infdis/jiy743
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1799
    Titles:
      – TitleFull: Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Folschweiller N
      – PersonEntity:
          Name:
            NameFull: Behre U
      – PersonEntity:
          Name:
            NameFull: Dionne M
      – PersonEntity:
          Name:
            NameFull: Durando P
      – PersonEntity:
          Name:
            NameFull: Esposito S
      – PersonEntity:
          Name:
            NameFull: Ferguson L
      – PersonEntity:
          Name:
            NameFull: Ferguson M
      – PersonEntity:
          Name:
            NameFull: Hillemanns P
      – PersonEntity:
          Name:
            NameFull: McNeil SA
      – PersonEntity:
          Name:
            NameFull: Peters K
      – PersonEntity:
          Name:
            NameFull: Ramjattan B
      – PersonEntity:
          Name:
            NameFull: Schwarz TF
      – PersonEntity:
          Name:
            NameFull: Supparatpinyo K
      – PersonEntity:
          Name:
            NameFull: Suryakirian PV
      – PersonEntity:
          Name:
            NameFull: Janssens M
      – PersonEntity:
          Name:
            NameFull: Moris P
      – PersonEntity:
          Name:
            NameFull: Decreux A
      – PersonEntity:
          Name:
            NameFull: Poncelet S
      – PersonEntity:
          Name:
            NameFull: Struyf F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 05
              M: 05
              Text: 2019 May 05
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6613
          Numbering:
            – Type: volume
              Value: 219
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: The Journal of infectious diseases
              Type: main
ResultId 1